SCHEMBL6508288

SCHEMBL6508288

CCc1cccc(C(=O)C(Br)c2ccnc(N)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.47
NOS1 P29475 1/20 0.47
NOS2 P35228 1/20 0.47
MAPK14 Q16539 1/20 0.39
SMYD3 Q9H7B4 1/20 0.37
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37
GABRA4 P48169 2/20 0.37
GABRE P78334 2/20 0.37
GABRA6 Q16445 2/20 0.37
GABRG1 Q8N1C3 2/20 0.37
GABRG3 Q99928 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3886670 0.99 NOS3 (0.46) NOS3NOS1NOS2MAPK14SMYD3
SCHEMBL6504706 0.91 KAT6A (0.37) NOS3NOS1NOS2MAPK14GABRP
Bromide SCHEMBL3890126 0.90 KAT6A (0.36) NOS3NOS1NOS2MAPK14GABRP
SCHEMBL6505974 0.85 PARP1 (0.44) GABRPGABRDGABRA1GABRB1GABRG2
Bromide SCHEMBL3887710 0.84 MAPK14 (0.38) MAPK14SMYD3BRAFBCL2PTGS2
Bromide SCHEMBL3892578 0.84 PARP1 (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL6505647 0.84 PARP1 (0.43) NOS3NOS1NOS2GABRPGABRD
Bromide SCHEMBL3889498 0.82 PARP1 (0.42) NOS3NOS1NOS2GABRPGABRD
Bromide SCHEMBL6283033 0.82 MAPK14 (0.39) MAPK14SMYD3LOXL2BCL2PTGS2
Bromide SCHEMBL3887674 0.81 CYP3A4 (0.38) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050080113-A1 Medicinal compositions TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080113-A1 Medicinal compositions TNF, TRAF6, MMP8 NOS3 108/4885NOS1 168/4885NOS2 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.